Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma

NCT00476268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

824

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: beclomethasone/formoterol (100/6µg) pMDI
DRUG: Beclometasone dipropionate 250 µg/unit dose pMDI
DRUG: Formoterol powder 12 µg/unit dose

Sponsor

Chiesi Farmaceutici S.p.A.